Nottingham Digestive Diseases Centre (NDDC), Translation Medical Sciences, School of Medicine, University of Nottingham, UK.
NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
J Int Med Res. 2022 Nov;50(11):3000605221140310. doi: 10.1177/03000605221140310.
To describe the different aetiologies of ascites and test the validity of serum ascites albumin gradient (SAAG) and cytology in a contemporary unselected medical cohort.
All adult patients admitted to Nottingham University Hospitals, UK, between 1 May 2013 and 30 April 2018 with new-onset radiologically-confirmed ascites were included. Data were analysed to determine the distribution of different aetiologies of ascites and the diagnostic accuracy of SAAG in portal hypertension and cytology in malignancy as underlying causes of ascites.
Over 5 years, 286 patients presented with new-onset ascites; 122 surgical cases were excluded. Most patients were men (n = 84, 51.2%) over 50 years of age (n = 142, 86.6%). Cirrhosis accounted for 54.9% (n = 90) of the cases of ascites followed by malignancy (n = 48, 29.3%) and cardiac failure (n = 10, 6.1%). SAAG ≥11 g/L had a sensitivity of 85.5% and specificity of 60.6% for diagnosing portal hypertension as a cause of ascites (diagnostic accuracy = 78.5%, 95% confidence interval (CI): 69.8-85.5; area under the curve (AUC) = 0.756, 95% CI: 0.652-0.860). Ascitic fluid cytology was positive in 50% of malignant cases and 66% of primary peritoneal carcinomatosis cases.
The underlying aetiology and the validity of available tests varied substantially compared with previous reports.
描述腹水的不同病因,并在当代未选择的医学队列中测试血清腹水白蛋白梯度(SAAG)和细胞学的有效性。
所有于 2013 年 5 月 1 日至 2018 年 4 月 30 日期间因新出现的放射学证实的腹水而在英国诺丁汉大学医院住院的成年患者均被纳入研究。对数据进行分析,以确定不同病因的腹水分布以及 SAAG 在门脉高压症中的诊断准确性和细胞学在恶性肿瘤作为腹水潜在病因中的诊断准确性。
5 年来,286 例患者出现新发性腹水;排除了 122 例手术病例。大多数患者为男性(n=84,51.2%),年龄超过 50 岁(n=142,86.6%)。肝硬化占腹水病例的 54.9%(n=90),其次是恶性肿瘤(n=48,29.3%)和心力衰竭(n=10,6.1%)。SAAG≥11g/L 对诊断门脉高压症为腹水的病因具有 85.5%的敏感性和 60.6%的特异性(诊断准确性=78.5%,95%置信区间(CI):69.8-85.5;曲线下面积(AUC)=0.756,95%CI:0.652-0.860)。腹水细胞学检查在 50%的恶性肿瘤病例和 66%的原发性腹膜癌病例中呈阳性。
与以往报告相比,潜在病因和现有检测的有效性差异很大。